In regard to the relationship between the status of EGFR and ALK (EGFR mutations, ALK fusions and EGFR/ALK co-alterations) and the clinical pathological features of patients with lung cancer, there are not many studies conducted. This evidence concerns the gene EGFR and lung carcinoma.